NCT03122964View on ClinicalTrials.gov

Multi Institutional Study in Patient Presenting With Hematuria

UnknownOBSERVATIONAL
Enrollment

1,148

Participants

Timeline

Start Date

March 31, 2017

Primary Completion Date

February 28, 2020

Study Completion Date

February 28, 2020

Conditions
Bladder CancerHematuria
Interventions
DIAGNOSTIC_TEST

AssureMDx

combined panel of methylation and mutation markers for the detection of bladder cancer

Trial Locations (1)

75390

UT Southwestern, Dallas

Sponsors

Lead Sponsor

MDx Health
All Listed Sponsors
lead

MDx Health

INDUSTRY

NCT03122964 - Multi Institutional Study in Patient Presenting With Hematuria | Biotech Hunter | Biotech Hunter